Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00881868 · ClinicalTrials.gov registry record · Phase 4
Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 81
- Enrollment target
NCT00881868 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 81 participants.
The verdict
NCT00881868, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 81 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the safety and efficacy of clobetasol propionate spray versus vehicle spray for the management of moderate to severe plaque psoriasis of the scalp.
Interventions
- DRUG clobetasol propionate spray 0.05%
- DRUG Vehicle spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00881868
The ClinicalTrials.gov registry entry for NCT00881868 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which clobetasol propionate spray 0.05% is the first listed.
NCT00881868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00881868 about?
NCT00881868 is a clinical study titled "Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp". The primary objective of this study is to evaluate the safety and efficacy of clobetasol propionate spray versus vehicle spray for the management of moderate to severe plaque psoriasis of the scalp.
What is the current status of trial NCT00881868?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 81 participants. The study started on 2009-04. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00881868?
The interventions under investigation include: clobetasol propionate spray 0.05% (DRUG), Vehicle spray (DRUG).
Who is sponsoring clinical trial NCT00881868?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.